Surgery Partners Stock EBITDA
| SGRY Stock | USD 25.87 0.08 0.31% |
Surgery Partners fundamentals help investors to digest information that contributes to Surgery Partners' financial success or failures. It also enables traders to predict the movement of Surgery Stock. The fundamental analysis module provides a way to measure Surgery Partners' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Surgery Partners stock.
Surgery |
Surgery Partners Company EBITDA Analysis
Surgery Partners' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Surgery Partners EBITDA | 446.1 M |
Most of Surgery Partners' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Surgery Partners is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, Surgery Partners reported earnings before interest,tax, depreciation and amortization of 446.1 M. This is 49.16% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The ebitda for all United States stocks is 88.56% higher than that of the company.
Surgery EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Surgery Partners' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Surgery Partners could also be used in its relative valuation, which is a method of valuing Surgery Partners by comparing valuation metrics of similar companies.Surgery Partners is currently under evaluation in ebitda category among its peers.
Surgery Fundamentals
| Return On Equity | 0.0308 | ||||
| Return On Asset | 0.039 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 6.59 B | ||||
| Shares Outstanding | 127.11 M | ||||
| Shares Owned By Insiders | 1.74 % | ||||
| Shares Owned By Institutions | 98.26 % | ||||
| Number Of Shares Shorted | 9.45 M | ||||
| Price To Earning | 61.84 X | ||||
| Price To Book | 1.73 X | ||||
| Price To Sales | 1.10 X | ||||
| Revenue | 2.74 B | ||||
| Gross Profit | 705.6 M | ||||
| EBITDA | 446.1 M | ||||
| Net Income | (11.9 M) | ||||
| Cash And Equivalents | 227.4 M | ||||
| Cash Per Share | 2.58 X | ||||
| Total Debt | 3.06 B | ||||
| Debt To Equity | 1.44 % | ||||
| Current Ratio | 1.51 X | ||||
| Book Value Per Share | 15.00 X | ||||
| Cash Flow From Operations | 293.8 M | ||||
| Short Ratio | 5.56 X | ||||
| Earnings Per Share | (0.47) X | ||||
| Price To Earnings To Growth | 1.66 X | ||||
| Target Price | 33.55 | ||||
| Number Of Employees | 10.5 K | ||||
| Beta | 2.61 | ||||
| Market Capitalization | 3.29 B | ||||
| Total Asset | 6.88 B | ||||
| Retained Earnings | (569.2 M) | ||||
| Working Capital | 372 M | ||||
| Current Asset | 310.96 M | ||||
| Current Liabilities | 181.29 M | ||||
| Net Asset | 6.88 B |
About Surgery Partners Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Surgery Partners's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Surgery Partners using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Surgery Partners based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.